Current therapeutic options for low‐risk papillary thyroid carcinoma: Scoping evidence review

Corresponding Author

Alvaro Sanabria MD, MSc, PhD

Department of Surgery, School of Medicine, Universidad de Antioquia/IPS Universitaria/Hospital Universitario San Vicente Fundación, Medellín, Colombia

CEXCA Centro de Excelencia en Enfermedades de Cabeza y Cuello/Clínica Las Vegas-grupo Quirónsalud, Medellín, Colombia

Correspondence

Alvaro Sanabria, Department of Surgery, School of Medicine, Universidad de Antioquia, Cra. 51d #62-29, Medellin, Colombia.

Email: alvarosanabria@gmail.com

Search for more papers by this author

Comments (0)

No login
gif